Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.
If you were prescribed this medicine, other products containing No active ingredients may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.
for Unguentum M is formulated to smooth and soften your skin. It replaces oils in your dry skin and stops your skin losing moisture. It will also relieve the itching caused by eczema and dermatitis. Unguentum M is used to treat dry, cracked and damaged skin caused by conditions like eczema, dermatitis, itchy skin (known as pruritus), or dry harsh scaly skin (known as ichthyosis).
It can also be used for the protection of raw and grazed skin areas. Unguentum M can also be used to help relieve the symptoms of nappy rash. You can also use Unguentum M instead of soap when washing which will help to prevent the skin drying out.
e Unguentum M Do not use Unguentum M
Sorbic acid (E200), cetostearyl alcohol and buthylhydroxytoluene (E321) may cause local skin reactions, (e.g. contact dermatitis which can be a rash or irritated skin and irritation to the eyes and mucous membranes). Propylene glycol (E1520) may cause skin irritation. Warning of fire hazard with emollients Do not smoke or go near naked flames – risk of severe burns. Fabric (clothing, bedding, dressings etc) that has been in contact with this product burns more easily and is a serious fire hazard. Washing clothing and bedding may reduce product build-up but not totally remove it.
Unguentum M Always use this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them. Rarely (1 in 10 out of 10,000 persons treated)
Unguentum M Keep this medicine out of the sight and reach of children. Aluminium tubes do not require any special storage condition. Plastic containers: Do not store above 25°C. Do not use Unguentum M after the expiry date which is stated on the label after "EXP". The expiry date refers to the last day of that month. After opening: Unguentum M can be used for 6 months. Do not throw away any medicines via wastewater <or household waste>. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
6. Content of the pack and other information What Unguentum M contains The ingredients are white soft paraffin (contains buthylhydroxytoluene (E321)), cetostearyl alcohol, polysorbate 40, propylene glycol (E1520), glyceryl monostearate 40-55, liquid paraffin, medium-chain triglycerides, sorbic acid (E200), colloidal anhydrous silica, purified water, sodium hydroxide What Unguentum M looks like and contents of the pack
Unguentum M is a white cream. Unguentum M cream is supplied in:
Unguentum M Cream comes as cream. Always follow the dose your doctor or pharmacist has given you, and read the leaflet that comes with the medicine.
The active substance in Unguentum M Cream is no active ingredients.
Medicines with the same active substance, strength and form include: Lipobase Cream. They are interchangeable only if your prescriber or pharmacist says so.
This leaflet reproduces the patient information leaflet approved for Unguentum M Cream, as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.
Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.
The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.
Unguentum M has emollient properties and is recommended for the symptomatic treatment of dermatitis, nappy rash, ichthyosis, eczema, protection of raw and abraded skin areas, pruritus and related skin conditions where dry scaly skin is a problem, and as a pre-bathing emollient for dry/eczematous skin, to alleviate drying effects.
Unguentum M is to be used as a diluent for various topical corticosteriod formulations in those instances where a lower strength preparation is considered desirable by the physician and as a general base for extemporaneous dispensing.
Posology
A thin application of the cream should be gently massaged into the skin three times daily or at appropriate intervals.
When used as a protective cream Unguentum M should be applied sparingly to the affected areas of the skin before, or immediately after, exposure to a potentially harmful factor.
Unguentum M should not be used:
- if hypersensitivity to any of the ingredients listed in section 6.1 is known.
- near the eyes and on mucous membranes.
Sorbic acid (E200) and Cetostearyl alcohol may cause local skin reactions, (e.g. contact dermatitis)
Propylene glycol (E1520) may cause skin reactions.
White soft paraffin contains buthylhydroxytoluene (E321) and may cause local skin reactions (e.g. contact dermatitis) or irritation to the eyes and mucous membranes.
Ingestion of Unguentum M should be avoided.
Fire Hazard with emollients
Instruct patients not to smoke or go near naked flames - risk of severe burns. Fabric (clothing, bedding, dressings etc) that has been in contact with this product burns more easily and is a serious fire hazard. Washing clothing and bedding may reduce product build-up but not totally remove it.
None.
No evidence of any harmful effect on the use of Unguentum M in pregnancy and lactation.
None.
Rarely (1 in 10 out of 10,000 persons treated) skin irritation such as burning sensations and reddening or allergic contact dermatitis may occur.
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme, Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
None.
Ask anything about Unguentum M Cream. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.
Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.
We use essential cookies to make the site work. We would also like to set optional cookies to understand how the site is used, so we can improve it. We will not set optional cookies unless you accept. See our cookie policy and privacy policy.